FIELD: biotechnology.
SUBSTANCE: described is a group of inventions comprising a conjugate for treating a viral infection caused by an influenza or parainfluenza virus, or a pharmaceutically acceptable salt thereof, the use of said conjugate for treating a viral infection caused by an influenza virus or a parainfluenza virus, a pharmaceutical composition for treating a viral infection caused by an influenza virus or a parainfluenza virus, containing a conjugate or a pharmaceutically acceptable salt thereof, a method of treating a subject having a viral infection caused by an influenza virus or a parainfluenza virus, and a method for preventive treatment of a viral infection caused by an influenza virus or a parainfluenza virus in a subject in need thereof.
EFFECT: invention extends the range of products for treating viral infection caused by influenza virus or parainfluenza virus.
30 cl, 68 dwg, 65 tbl, 147 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PRODRUG COMPOSITIONS BASED ON CROSS-LINKED HYALURONIC ACID HYDROGEL AND METHODS OF THEIR PRODUCTION | 2018 |
|
RU2812787C2 |
| PEPTIDOMIMETIC COMPOUNDS AND THEIR CONJUGATES OF ANTIBODIES WITH DRUGS | 2014 |
|
RU2689388C1 |
| AGONIST OF THE GLUCOCORTICOID RECEPTOR AND ITS IMMUNOCONJUGATES | 2017 |
|
RU2745748C2 |
| COMPOSITIONS AND METHODS OF USING FOR TREATING METABOLIC DISORDERS | 2014 |
|
RU2704285C2 |
| ANTIBODIES AGAINST TEICHOIC ACID CONJUGATE AND THEIR CONJUGATES | 2014 |
|
RU2687044C2 |
| DELAYED-RELEASE DELIVERY SYSTEMS CONTAINING TRACELESS LINKERS | 2018 |
|
RU2772690C2 |
| ANTIBODY-DRUG CONJUGATES AND METHODS OF USING SAID CONJUGATES OF PYRROLOBENZODIAZEPINE | 2016 |
|
RU2736725C1 |
| ANTI-CD22 ANTIBODY-MAITANSIN CONJUGATES AND METHODS OF THEIR APPLICATION | 2016 |
|
RU2744895C2 |
| CONJUGATES OF ENGINEERED ANTIBODIES WITH CYSTEINE SUBSTITUTES | 2016 |
|
RU2733740C2 |
| INSULIN CONJUGATES | 2019 |
|
RU2809189C2 |
